Back to catalog
Local adipogenesis research
Topical Rosiglitazone
10mL, 5mg/mL
A transdermal formulation for research into local adipogenesis.
Overview
Topical Rosiglitazone is a thiazolidinedione derivative used in research to investigate localized adipose tissue modulation. It has been examined for its role in influencing adipocyte differentiation and lipid metabolism.
Mechanism of action
It acts as a selective agonist for the peroxisome proliferator-activated receptor gamma (PPARγ).
Dosage & concentration
5 mg/mL concentration. 10 mL bottle contains 50 mg total.
Storage & handling
Keep at room temperature, protected from light and moisture.
Research & studies
- The autophagic regulation of rosiglitazone-promoted adipocyte browning.Front Pharmacol · 2024
- Rosiglitazone-induced white adipocyte browning is regulated by actin and Myh9.Life Sci · 2024
- Development of an adipocyte differentiation protocol using 3T3-L1 cells for the investigation of the browning process: identification of the PPAR-γ agonist rosiglitazone as a browning reference drug.Front Pharmacol · 2025